DOW JONES21,413.44+469.93 2.24%
S&P 5002,526.90+56.40 2.28%
NASDAQ7,487.31+126.73 1.72%

Nabriva Therapeutics Q4 EPS $(0.29) Up From $(0.46) YoY

Nabriva Therapeutics (NASDAQ:NBRV) reported quarterly losses of $(0.29) per share. This is a 36.96 percent increase over losses of $(0.46) per share from the same period last year.

Benzinga · 03/12/2020 20:09

Nabriva Therapeutics (NASDAQ:NBRV) reported quarterly losses of $(0.29) per share. This is a 36.96 percent increase over losses of $(0.46) per share from the same period last year.